The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology
Open accessAbstract
Microglial cells closely interact with senile plaques in Alzheimer's disease and acquire the morphological appearance of an activated phenotype. The significance of this microglial phenotype and the impact of microglia for disease progression have remained controversial. To uncover and characterize putative changes in the functionality of microglia during Alzheimer's disease, we directly assessed microglial behavior in two mouse models of Alzheimer's disease. Using in vivo two-photon microscopy and acute brain slice preparations, we found that important microglial functions - directed process motility and phagocytic activity - were strongly impaired in mice with Alzheimer's disease-like pathology compared to age-matched non-transgenic animals. Notably, impairment of microglial function temporally and spatially correlated with Aβ plaque deposition, and phagocytic capacity of microglia could be restored by interventionally decreasing amyloid burden by Aβ vaccination. These data suggest that major microglial functions progressively decline in Alzheimer's disease with the appearance of Aβ plaques, and that this functional impairment is reversible by lowering Aβ burden, e.g. by means of Aβ vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, previous studies have shown that microglial function may be adversely affected by Aβ, particularly as a result of chronic exposure to pro-inflammatory cytokines, resulting in increased Aβ accumulation and potentially underpinning the contradiction between our in vitro and in vivo results.39,40”
From Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the ability of microglia to remove Αβ declines over time”
From Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease (2025) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting that the progression of amyloid pathology correlates with impaired capacity of microglia to phagocytose Αβ17,16.”
From Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease (2025) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“their phagocytic capacity declines with aging, chronic exposure to Αβ, and during sustained inflammation in the AD brain76,16,17.”
From Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease (2025) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, perturbations in microglial activity, often associated with aging, can affect the effective clearance of these neuron-derived Aβ fibrils, leading to increased plaque formation and the progression of cognitive and behavioral impairments (17–20).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Microglial phagocytosis is believed to be dysfunctional in AD [17–19].”
From IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia (2019) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“However, several studies have shown that defects in the phagocytic function of microglia can be restored with Aβ immunization [18, 23] and anti-inflammatory drug treatment [24, 25].”
From IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia (2019) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Notably, microglial process motility directed toward site of damage was significantly impaired in mice with A β plaques 48 .”
From Transcriptomic analysis of purified human cortical microglia reveals age-associated changes (2017) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“To investigate a second biologically relevant microglial function we studied process motility by assessing process extensions towards an acute injury induced by a laser lesion [1,2].”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 3×
“Microglia respond to defined tissue injuries by extending their processes towards the lesion in an ATP-dependent fashion [2].”
BackgroundMethodMicroglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 1×
“process and the morphology of microglial cells does not necessarily match their functional state [14,15].”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632 · cited 2×
“1A and B and Videos S1 and S2), which were obtained by crossbreeding APPPS1 mice, a mouse model of cerebral amyloidosis [21] with Cx3cr1 mice [23], a mouse model that allows visualization of microglia.”
MethodMicroglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622 · cited 1×
“newborn neuroblasts [5].”
Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., & Nabekura, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4363-08.2009 · Cited by 1,619 · cited 1×
“neuronal structure [3,4].”
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · cited 2×
“APP23 mice, which express APP with the Swedish mutation [22] were provided by Novartis, Basel, Switzerland.”
BackgroundMethodMicroglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 4×
“Interestingly, expression of receptors and enzymes involved in microglial Ab-uptake and degradation is progressively downregulated in a transgenic mouse model of Alzheimer’s disease [20].”
BackgroundResultInfluentialMCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 1×
“A number of in vitro studies have not only shown that administration of Ab stimulates the production of inflammatory cytokines and activation markers in microglial cells [8] but also triggers its uptake by receptor-mediated phagocytosis [16].”
BackgroundLee, J.-H., Yu, W. H., Kumar, A., Lee, S., Mohan, P. S., Peterhoff, C. M., Wolfe, D. M., Martinez-Vicente, M., Massey, A. C., Sovak, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.008 · Cited by 1,212
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–483 of 483
Mishra, P., Silva, A., Sharma, J., Nguyen, J., Pizzo, D. P., Sahoo, D., & Cherqui, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1602615/v1 · Cited by 2
Park, T., Chang, L., Chung, S. W., Lee, S., Bae, S., Condello, C., Kim, Y. H., Lee, J., Kim, H.-J., Kwon, H.-K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.13.612389 · Cited by 2
“Given that Aβ plaques tend to suppress P2RY12 expression ( 20, 60 ), impair microglial function ( 12 ), and directly affect neuronal activity ( 15 ), it is essential to delineate whether these effects are primarily driven by IL-10/TGF-β signaling or occur secondary to enhanced plaque clearance.”
Fulopova, B., Bennett, W. R., Summers, B. S., Stuart, K. E., King, A. E., Vickers, J. C., & Canty, A. J. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.007 · Cited by 1
Patel, B., Walker, R., Capó, M., Cusimano, N., Comas, J., Garcia, D., Cruickshank, G. S., & Ginn, C. (2023) · Medical Research Archives · doi:10.18103/mra.v11i7.2.3971 · Cited by 1
Astillero‐Lopez, V., Villar‐Conde, S., González-Rodríguez, M., Flores‐Cuadrado, A., Úbeda‐Bañón, I., Saiz‐Sánchez, D., & Martínez-Marcos, A. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.08.680 · Cited by 1
Exploring Gene Therapy Modalities for Neuroinflammation Control in Alzheimer’s Disease Pathogenesis
Kadiri, S. K., & Tiwari, P. K. (2025) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/0118756921377967250714173056 · Cited by 1
EGR2 maintains neuropathic pain by promoting microglial phagocytosis.
Xi, C., Zhang, J., Huang, Z., He, L., Zou, K., Xu, X., Guo, Q., Sun, B., & Huang, C. (2025) · PubMed Central · doi:10.11817/j.issn.1672-7347.2025.240270 · Cited by 1
Gao, P.-P., Zhou, F.-L., Zheng, G.-B., Liu, Y., Cheng, S., Ye, Z., Liang, Y.-T., Liu, L., Guo, L., & Lin, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1835714 · Cited by 2
“Yet , as disease progresses, microglial function becomes impaired, diminishing their capacity to clear A β , which contributes to disease progression and cognitive decline (32, 33).”
New Insights into Microglia as Therapeutic Targets in Alzheimer’s Disease
Mandlik, D. S., Mandlik, S. K., & Choudhary, H. B. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230427100702 · Cited by 2
Gimeno-Ferrer, F., Eitner, A., Noora, N., Bauer, R., Schmidt‐Hieber, C., Schaible, H., & Richter, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-57868-4 · Cited by 2
“Consistent with a previous study on TASTPM mice 28 , the first plaques were detected at 6 months of age, and much larger plaques were observed at 12 months of age.”
ResultTargeting Neuroglial Sodium Channels in Neuroinflammatory Diseases
Yao, Y., Wang, X., Zhang, S., Zhang, Z., Wang, W., Zhu, Y., Cheng, J., Li, G., & Tao, J. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92127 · Cited by 1
Mild Cognitive Impairment and Early Dementia
Damasceno, B. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-57267-9_20 · Cited by 1
Neuroinflammation in Alzheimer's Disease Continuum
Sag, A. T., & Yemişçi, M. (2020) · Neurological Sciences and Neurophysiology · doi:10.4103/nsn.nsn_190_20 · Cited by 1
The role of tau and neuroinflammation in Progressive Supranuclear Palsy and Alzheimer's Disease
Rodríguez, P. V. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.45106 · Cited by 1
“Indeed, in cortical tissue specimens from patients with AD, the microglia surrounding plaques are impaired at amyloid-β uptake (Frackowiak et al., 1992; Krabbe et al., 2013).”
BackgroundHippocampal neurogenesis and dementia risk in age and disease
Mathews, K. J. (2019) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 1
Acoustic pH sensor for dynamic ultrasound imaging of cellular acidificationPreprint
Terwiel, D., Park, B. M., Heiles, B., Waasdorp, R., Muñoz-Ibarra, E., Ara, T., Gazzola, V., & Maresca, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.24.634762 · Cited by 1
Liu, T., Ko, E., Yang, Y., Wu, H., Unjitwattana, T., Wang, S., Kang, J., Li, Y., & Garmire, L. X. (2025) · medRxiv · doi:10.1101/2025.08.09.25333297 · Cited by 1
“Enrichment of Negative regulation of cell motility (GO:2000146) has been implicated in Alzheimer's disease, primarily reflecting impaired microglial migration and reduced cytoskeletal plasticity, which may hinder the clearance of amyloid plaques and disrupt neuroinflammatory responses 40 .”
Gerstenmayer, M. (2018) · theses.fr (ABES) · doi:10.70675/5aa7fd45z24caz43e9zaaadzeb1ca21e8661 · Cited by 1
Prevention of Blast-Related Injuries
King, A., Cavanaugh, J., Yang, K. H., Zhang, L.-Y., Jin, X., & Zhu, F. (2015) · doi:10.21236/ada615108
Neurotransmitter and neurohormone receptors on microglia
Pannell, M. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-16079
Bone Marrow-Derived Cell Accumulation in the Brain in a Murine Model of Alzheimer’s Disease
Barr, C. (2013) · Summit (Simon Fraser University)
Purification and characterisation of the ectodomain of the scavenger receptor CD36
Sanders, D. J. (2014)
Murphy, S. M., & Husselbee, K. (2013) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304107.191
Microglia: Features of Polarization and Aging
Harry, G. J., & McPherson, C. A. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_3
Imaging Amnestic Mild Cognitive Impairment: Neuroinflammation, Beta-amyloid and Glutathione
Knezevic, D. (2016) · TSpace (University of Toronto)
Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease?
Gómez, O., Pintado, C., Rodríguez-Pérez, M., & Burgos‐Ramos, E. (2019) · Frontiers in clinical drug research. Alzheimer disorders · doi:10.2174/9789811401893119080005
Modelling the neurobiology of Alzheimer’s disease in vitro
Muñoz, S. S. (2019) · Research Online (University of Wollongong)
The interaction of neutrophils and amyloid-ß in Alzheimer’s disease
Hill, M. J. (2020) · Otago University Research Archive (University of Otago)
Russell, A. E. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.3947
Amyloid-beta uptake by peripheral blood monocytes is reduced by ageing and Alzheimer’s diseasePreprint
Chen, S.-H., Tian, D., Shen, Y., Cheng, Y., Fan, D., Sun, H., He, C.-Y., Sun, P., Bu, X., Zeng, F., et al. (2020) · doi:10.21203/rs.3.rs-33566/v1
“Page 4/21 capacity of microglia in the brain is a major mechanism underlying the development of AD (8, 9).”
BackgroundSmirnova, A. A., Прахова, Л. Н., & Ilves, A. G. (2021) · Russian neurological Journal · doi:10.30629/2658-7947-2021-26-5-4-15
Exploring sphingolipid function in the pathogenesis of Alzheimer’s disease
Luo, Q. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220215ql
Amyloid-beta Uptake by Peripheral Blood Monocytes is Reduced by Ageing and Alzheimer’s DiseasePreprint
Chen, S.-H., Tian, D., Shen, Y., Cheng, Y., Fan, D., Sun, H., He, C.-Y., Sun, P., Bu, X., Zeng, F., et al. (2020) · doi:10.21203/rs.3.rs-37808/v1
Cellular Mechanisms of Dementia
Gan, L. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0054
Faculty Opinions recommendation of Neuroinflammation in Alzheimer's disease.
Perani, D. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725413893.793537457
AVE 0991 suppresses neuroinflammation of Alzheimer's disease by enhancing autophagy in astrocytesPreprint
Deng, Y., Wang, S., Wang, Q., Xu, Z., Peng, Q., Chen, S., Zhu, L., Zhang, Y., & Duan, R. (2022) · Research Square · doi:10.21203/rs.3.rs-1967115/v1
Therapeutic and immunomodulatory functions of the translocator protein in Alzheimer's disease
Fairley, L. H. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/160865
Amyloidosis and ageing have differential effects on microglial Ca 2+ activity in the mouse brainPreprint
Izquierdo, P., Jolivet, R., Attwell, D., & Madry, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.10.552670
“We first assessed whether microglial morphology was affected by proximity to Aβ plaques, as has been shown previously in other non-knock-in models of AD, which have a differing development of disease parameters [47–49].”
Hanotte, J. L. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/161150
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Figshare · doi:10.6084/m9.figshare.14945066
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Figshare · doi:10.6084/m9.figshare.14945063
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Figshare · doi:10.6084/m9.figshare.14945060
Gut Microbiota in Circadian Rhythm and Alzheimer’s Disease
Wang, J. (2024) · MedScien · doi:10.61173/q639ws46
Synaptic Photodamage and Its Application to Study Microglia–Synapse Interactions In Vivo
Cangalaya, C., & Dityatev, A. E. (2024) · Neuromethods · doi:10.1007/978-1-0716-4011-1_5
Aerbajinai, W., Zhu, J., Chin, K., & Rodgers, G. P. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae197
Role of Glial Cells in Neurodegenerative Diseases and Metals-Induced Neurotoxicity
Pajarillo, E. A. B., Nyarko‐Danquah, I., Digman, A., Kim, S., Ajayi, I., Aschner, M., & Lee, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00227-8
Huang, L., Liu, Q., Ma, Z., Xue, J., Tian, X., Zhao, X., Zheng, Y., Wei, X., Yu, X., Feng, Y., et al. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250594
Role and relation of cell death in Alzheimer’s disease
Hoang, D. A., Le, D. A., Do, T. M. H., & Than, V. T. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2025.06.024
Alzheimer’s Disease: Pathophysiological and Therapeutical Insights
Tyagi, K., Sarup, P., & Malik, J. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_1 · Cited by 1
Liu, H., Li, J., Wang, X., Luo, S., Luo, D., Ge, W., & Ma, C. (2024) · Figshare · doi:10.6084/m9.figshare.26703235
Freitag, K., Sterczyk, N., Wendlinger, S., Obermayer, B., Schulz, J., Farztdinov, V. M., Mülleder, M., Ralser, M., Houtman, J., Fleck, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20221960
Self-citationCrivelli, S. M., Luo, Q., Stevens, J., Giovagnoni, C., van Kruining, D., Bode, G. H., den Hoedt, S., Hobo, B., Scheithauer, A.-L., Walter, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14053548
Additional file 1 of Microglial amyloid beta clearance is driven by PIEZO1 channels
Jäntti, H., Sitnikova, V., Ishchenko, Y., Shakirzyanova, A., Giudice, L., Ugidos, I. F., Gómez‐Budia, M., Korvenlaita, N., Ohtonen, S., Belaya, I., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080821
Logiacco, F., Grzegorzek, L. C., Cordell, E., Popp, O., Mertins, P., Gutmann, D. H., Kettenmann, H., & Semtner, M. (2023) · Figshare · doi:10.6084/m9.figshare.22621966
Self-citationCrivelli, S. M., Luo, Q., Stevens, J., Giovagnoni, C., van Kruining, D., Bode, G. H., den Hoedt, S., Hobo, B., Scheithauer, A.-L., Walter, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14053545
Crivelli, S. M., Luo, Q., Stevens, J., Giovagnoni, C., van Kruining, D., Bode, G. H., den Hoedt, S., Hobo, B., Scheithauer, A.-L., Walter, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14053551
Freitag, K., Sterczyk, N., Wendlinger, S., Obermayer, B., Schulz, J., Farztdinov, V. M., Mülleder, M., Ralser, M., Houtman, J., Fleck, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20221954
Self-citationLiu, H., Li, J., Wang, X., Luo, S., Luo, D., Ge, W., & Ma, C. (2024) · Figshare · doi:10.6084/m9.figshare.26703238
Mizrachi, M., & Diamond, B. (2024) · Figshare · doi:10.6084/m9.figshare.26703556
Induced-pluripotent stem cell-derived immunotherapy for Tau and Alzheimer’s disease
Chinnathambi, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.005
Therapeutics immunotargets for Tauopathy
Chinnathambi, S., & Rangappa, N. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.015
Kumari, P., & Singh, L. (2026) · NeuroMolecular Medicine · doi:10.1007/s12017-026-08908-x
“Moreover, it has been evident that increased production of Aβ promotes neuroinflammation that further stimulates the production of Aβ and alters the activity of microglial cells (Krabbe et al., 2013; Rather et al., 2021 ).”
Kerslake, L. D., Noonan, C., Davies, D., Kim, D., Eshou, V. A., Goldsbury, C. S., & Cullen, K. M. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.03.004
Rôle du peptide amyloïde dans les maladies neurodégénératives
Combes, M. (2018) · theses.fr (ABES) · doi:10.70675/a219ef4dzbca0z4272z8bf2z74080a1976e5 · Cited by 1
Étude des microARNs dans les vésicules extracellulaires microgliales : signatures et neuroprotection
Lemaire, Q. (2019) · theses.fr (ABES) · doi:10.70675/3a61ee49zc6e9z4a3cz9e2dzb1c527312127
Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953
Étude de la composante neuroinflammatoire dans les DFT/SLA
Smeyers, J. (2020) · theses.fr (ABES) · doi:10.70675/219cfa6fz5b3az4198z9deczdfaad3cd784c
Linard, M. (2021) · theses.fr (ABES) · doi:10.70675/792b3731z2670z4aedza18ezcd3259857759
Abdelouahab, O. B. (2021) · theses.fr (ABES) · doi:10.70675/97f4885fz3f5cz4234zb8e2ze3fa7c4e3d41
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Lam, S. (2021) · theses.fr (ABES) · doi:10.70675/60b353ffz56fcz41a2z9e53zf0d9ac078167 · Cited by 1
Contributions of vascular ageing to late‐onset Alzheimer's disease
Ferguson, S. J., Choi, Y. D., & Walker, A. E. (2026) · Experimental Physiology · doi:10.1113/ep092909 · Cited by 1
“Studies with AD mouse models have shown microglia to become less efficient in A β clearance, accompanied by decreased microglial phagocytic activity and increased A β plaque burden (Krabbe et al., 2013).”
Exploring peripheral immune mechanisms and potential therapeutic drugs for Alzheimer’s disease
Zhu, W., Zhou, D., Zhang, G., & Dai, W. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05397-4
“Although microglia play a role in clearing Aβ (Ries, M.andSastre, M. 2016; Wilkinson, K.andEl Khoury, J. 2012), their over-activation triggers chronic inflammation (Chen et al. 2006; Krabbe et al. 2013), weakening this capacity and exacerbating neuronal damage (Sochocka et al. 2017).”
Lima, M. N., Santos, L. F., Lemos, F. S., Reis, P. A., Maron‐Gutierrez, T., & Castro-Faria-Neto, H. C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1663796
A mechanistic framework linking the oral microbiome to Alzheimer's disease through neuroinflammation
Evers, M. J. A. P., Krom, B. P., & de Jongh, C. A. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261456324
“42 This would suggest that if these “ hyperactive ” microglia would become less active, the accumulation of A β would decrease.”
da Silva, A. B. G., Silva, S., Macedo, J., Moreira, P., Baptista, D., Bicker, J., Fortuna, A., Liberal, J. M. T., Rodrigues, B. R. I., Resende, R., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202601575r
“Iba1 is essential for microglial migration and phagocytosis, functions that have been demonstrated to be altered in AD [84].”
Park, T., Chang, L., Chung, S. W., Lee, S., Bae, S., Condello, C., Kim, Y. H., Lee, J., Kim, H.-J., Kwon, H., et al. (2026) · Science Advances · doi:10.1126/sciadv.adx0731 · Cited by 4
Roy, J., Tsui, K. C., Poon, C. H., Zhang, J., Lai, Y., Wong, K. Y., Mihardja, M., Tse, V., Li, P. C., Au, C., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.107077
Metadata
- Authors
- Krabbe, G., Halle, A., Matyash, V., Rinnenthal, J. L., Eom, G. D., Bernhardt, U., Miller, K. R., Prokop, S., Kettenmann, H., & Heppner, F. L.
- Affiliations
- Max Delbrück Center (DE)
- Center of Advanced European Studies and Research (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Kettenmann, Helmut
- Heppner, Frank L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-08
- Volume
- 8
- Issue
- 4
- Pages
- e60921
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3620049
- OpenAlex
- W2044090829
- Cited by
- 478
- References
- 41
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 31 · 2023: 25 · 2022: 44 · 2021: 56 · 2020: 40 · 2019: 41 · 2018: 38 · 2017: 38 · 2016: 33 · 2015: 39 · 2014: 34 · 2013: 13
- FWCI
- 22.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Max Planck Digital Library (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- European Commission (FP7 HEALTH)
- Deutsche Forschungsgemeinschaft (SFB TRR 43, NeuroCure EXC257, GRK1258, EXC257)
- Jung-Stiftung für Wissenschaft und Forschung
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS046006, NS046006)
- FP7 Health
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- microglia, Alzheimer's disease, amyloid plaques, microglial activation, microglial phagocytosis, mouse models of Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Animals, Cell Movement, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Mutation, Phagocytosis, Amyloid beta-Peptides, Protein Structure, Secondary, Microglia, Mice, Protein Multimerization, Plaque, Amyloid, Spatio-Temporal Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
